MXCT
MaxCyte Inc
NASDAQ: MXCT · HEALTHCARE · MEDICAL DEVICES
$0.84
-3.24% today
Updated 2026-05-08
Market cap
$90.34M
P/E ratio
—
P/S ratio
2.74x
EPS (TTM)
$-0.42
Dividend yield
—
52W range
$1 – $2
Volume
0.9M
MaxCyte Inc (MXCT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.84M | $2.50M | $6.30M | $6.40M | $16.07M | $31.40M | $24.27M | $29.99M | $51.78M | $284.12M | $286.65M | $268.27M | $239.47M |
| Cash & equivalents | $1.42M | $764900.00 | $3.41M | $2.41M | $11.73M | $25.34M | $11.25M | $15.21M | $18.76M | $47.78M | $11.06M | $46.51M | $27.88M |
| Current assets | $2.61M | $2.32M | $6.03M | $6.19M | $15.79M | $30.55M | $22.45M | $24.45M | $45.25M | $270.43M | $252.27M | $190.19M | $171.68M |
| Total liabilities | $3.43M | $4.05M | $7.95M | $9.48M | $10.99M | $11.80M | $11.99M | $16.38M | $18.55M | $21.22M | $32.69M | $36.11M | $33.22M |
| Current liabilities | $3.38M | $3.99M | $4.28M | $5.09M | $5.65M | $7.24M | $6.57M | $9.34M | $11.61M | $15.62M | $15.43M | $17.86M | $15.78M |
| Long-term debt | — | — | — | — | — | $4.18M | $5.06M | $4.90M | $4.92M | — | — | — | — |
| Shareholder equity | $-590700.00 | $-1.54M | $-1.65M | $-3.08M | $5.08M | $19.60M | $12.28M | $13.60M | $33.23M | $262.90M | $253.97M | $232.17M | $206.25M |
| Retained earnings | $-31.37M | $-33.85M | $-45.41M | $-48.38M | $-51.72M | $-61.64M | $-70.51M | $-83.41M | $-95.22M | $-114.30M | $-137.88M | $-175.80M | $-216.85M |
| Accounts receivable | $621700.00 | $767100.00 | $1.40M | $1.45M | $2.41M | $3.20M | $4.90M | $3.24M | $5.17M | $6.88M | $11.18M | $5.78M | $4.68M |
| Inventory | $514900.00 | $726800.00 | $941100.00 | $1.09M | $1.33M | $1.35M | $2.24M | $3.70M | $4.32M | $5.20M | $8.58M | $12.23M | $8.91M |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — |